Xintao Li
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Surgery top 10%
- Oncology top 10%
- Topics
- Renal cell carcinoma treatment (26 papers)Renal and related cancers (17 papers)Bladder and Urothelial Cancer Treatments (12 papers)
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xintao Li
81 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 120
- Molecular Biology 836
- Pulmonary and Respiratory Medicine 659
- Cancer Research 570
- Surgery 481
- Oncology 423
Countries citing papers authored by Xintao Li
This map shows the geographic impact of Xintao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xintao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xintao Li more than expected).
Fields of papers citing papers by Xintao Li
This network shows the impact of papers produced by Xintao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xintao Li. The network helps show where Xintao Li may publish in the future.
Co-authorship network of co-authors of Xintao Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xintao Li. A scholar is included among the top collaborators of Xintao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xintao Li. Xintao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 21 | |
| 6 | 21 | |
| 7 | 1 | |
| 8 | 9 | |
| 9 | 14 | |
| 10 | 1 | |
| 11 | 11 | |
| 12 | 8 | |
| 13 | 9 | |
| 14 | 67 | |
| 15 | 19 | |
| 16 | 63 | |
| 17 | 12 | |
| 18 | 54 | |
| 19 | 52 | |
| 20 | 5 |
About Xintao Li
Xintao Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 85 papers that have together received 2.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (26 papers), Renal and related cancers (17 papers) and Bladder and Urothelial Cancer Treatments (12 papers). The work is most often cited by research in Cancer Research (570 citations), Pulmonary and Respiratory Medicine (659 citations) and Oncology (423 citations). Xintao Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Liangyou Gu, Xin Ma, Yu Gao, Hongzhao Li, Xu Zhang, Yongpeng Xie, Luyao Chen, Qingbo Huang, Xu Zhang and Bo Guan. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.